Biochemical marker testing has revolutionized the approach to diagnosis and management
of heart failure over the past decade. There is an unsurpassed excitement in the heart failure …

Results. The resulting draft guidelines can be viewed in their entirety at on the NACB World
Wide Web site (http://www. aacc. org/AACC/members/nacb/LMPG/OnlineGuide …

BACKGROUND: Heart failure still maintains a high mortality. Biomarkers reflecting different
pathophysiological pathways are under evaluation to better stratify the mortality risk. The …

Abstract Objectives BNP and NT-proBNP are viewed as comparable in their ability to
diagnose and monitor HF in clinical guidelines. However, no recent large-scale study has …

Our purpose was to determine the test performance characteristics of BNP and NT-proBNP
in the diagnosis of heart failure for patients presenting to an emergency department or …

Guidelines for the pharmacological treatment of heart failure (HF) are based on results from
large clinical trials demonstrating benefit. State of the art pharmacological management of …

Heart failure (HF) is a significant cause of morbidity and mortality worldwide. Circulating
biomarkers reflecting pathophysiological pathways involved in HF development and …

Biomarkers have become an integral part of practicing medicine, especially in heart failure.
The natriuretic peptides are commonly used in the evaluation of heart failure, but their role …

Recently, the 4th Universal Definition of Myocardial Infarction was published. 1 Perhaps it is
time to consider a First Universal Definition of Heart Failure. Objective, clinically verifiable …

Heart failure (HF) results from the impaired ability of heart to fill or pump out blood. HF is a
common health problem with a multitude of causes and affects~ 30 million people …